1/n Reliance Industries Ltd announces results for Q3 & 9m FY2020-21. Details follow… #RILresults

2/n Q3 FY2020-21 Reliance reports strong sequential rebound across all the businesses #RILresults
3/n Reliance posts highest ever consolidated quarterly Net Profit; Q3 FY2020-21 PAT at Rs 15,015 crore, up 24.9% (Excluding EO) #RILresults
4/n Q3 FY2020-21 Consolidated quarterly EBITDA up 12.0% Q-o-Q to a record Rs 26,094 crore #RILresults
5/n Q3 FY2020-21 Strong 38.2% sequential jump in quarterly EPS to Rs 20.5 per share (Excluding EO) #RILresults
6/n Q3 FY2020-21 Digital Services report record high profits; Q3 FY21 EBITDA at Rs 8,942 crore, up 48.4% Y-o-Y @RelianceJio #RILresults
7/n Q3 FY2020-21 Robust recovery in Retail performance; EBITDA at record high of Rs 3,102 crore, up 52.9% Q-o-Q #RILresults
8/n Reliance Industries generated over 50,000 new jobs in COVID times #RILresults
9/n Q3 FY2020-21 Jio Platforms revenue including access revenues for the quarter was Rs 22,858 crore ($3.1 billion), up 5.3% sequentially @RelianceJio #RILresults
10/n Q3 FY2020-21 Jio Platforms EBITDA for the quarter was Rs 8,483 crore ($1.2 billion), an increase of 6.4% #RILresults
11/n Q3 FY2020-21 Jio Platforms net profit for the quarter was Rs 3,489 crore ($477 million) growth of 15.5% Q-o-Q #RILresults
12/n Q3 FY2020-21 @RelianceJio total subscriber base as at end Dec 2020 stood at 410.8 million, with gross addition of 25.1 million customers during the quarter #RILresults
13/n Q3 FY2020-21 @RelianceJio’s ARPU during the quarter improved to ₹151.0 per month, as against ₹145.0 in the trailing quarter #RILresults
14/n Q3 FY2020-21 @RelianceJio’s customer engagement continued to improve with average monthly data consumption per user rising to 12.9 GB from 12.0 GB in trailing quarter #RILresults
15/n Q3 FY2020-21 @RelianceJio's total data traffic during the quarter improved 4% sequentially to 1,586 crore GB; voice traffic grew 4.6% sequentially to 97,496 crore minutes #RILresults
16/n Q3 FY2020-21 @RelianceJio’s FTTH services witnessed increased uptake during the quarter on the back of unique offering and widespread network across the country #RILresults
17/n Q3 FY2020-21 Reliance Retail posted a strong jump in EBITDA margins to 9.3% – as against 5.5% in trailing quarter – as COVID related curbs on store operations eased during the quarter #RILresults
18/n Q3 FY2020-21 Reliance Retail's topline stagnated as fuel retailing business was transferred out and Reliance Market stores were converted to fulfilment centers to support New Commerce #RILresults
19/n Q3 FY2020-21 Apparel & Footwear business staged a strong bounce back driven by impactful event activation, which led to strong festive season performance and enabled 1.5X growth over last quarter #RILresults
20/n Q3 FY2020-21 AJIO continues to scale new highs with 5X growth in orders over previous year and significant improvement across customer metrics and operating parameters #RILresults
21/n Q3 FY2020-21 Digital commerce momentum continued with orders up 12X Y-o-Y alongside growth in portfolio, traffic and customer base across platforms #RILresults
22/n Q3 FY2020-21 Track record of expansion continues with more stores, more orders and more merchant partnerships; Added 327 new stores taking total store count to 12,201 spread over 31.2 million sq. ft. #RILresults
23/n Q3 FY2020-21 Reliance integrates Oil-to-Chemicals business; Single management team for day-to-day operations; To drive integrated planning and optimization across the hydrocarbon value chain #RILresults
24/n Q3 FY2020-21 Strong demand revival for polyester and polymers drive O2C segment’s Q3 FY21 EBITDA up 10.3% to Rs 9,756 crore #RILresults
n/n Q3 FY2020-21 Q3 capacity utilization improves across O2C sites; Total throughput for the quarter improves 8.3% sequentially to 18.2 million tonne #RILresults

More from Business

You May Also Like

@franciscodeasis https://t.co/OuQaBRFPu7
Unfortunately the "This work includes the identification of viral sequences in bat samples, and has resulted in the isolation of three bat SARS-related coronaviruses that are now used as reagents to test therapeutics and vaccines." were BEFORE the


chimeric infectious clone grants were there.https://t.co/DAArwFkz6v is in 2017, Rs4231.
https://t.co/UgXygDjYbW is in 2016, RsSHC014 and RsWIV16.
https://t.co/krO69CsJ94 is in 2013, RsWIV1. notice that this is before the beginning of the project

starting in 2016. Also remember that they told about only 3 isolates/live viruses. RsSHC014 is a live infectious clone that is just as alive as those other "Isolates".

P.D. somehow is able to use funds that he have yet recieved yet, and send results and sequences from late 2019 back in time into 2015,2013 and 2016!

https://t.co/4wC7k1Lh54 Ref 3: Why ALL your pangolin samples were PCR negative? to avoid deep sequencing and accidentally reveal Paguma Larvata and Oryctolagus Cuniculus?